Biocon’s Brazil pact could lower pertuzumab costs for public patients by expanding biosimilar access and supporting local manufacturing.
India’s peptide API race heats up as HRV Pharma commits Rs 150 crore to expand synthetic peptide and high-potency oncology API capacity.
The obesity drug market swings between big wins and bigger doubts as new trial results, rising sales and treatment limits reshape the industry.
Roche Pharma India announced the winners of the third edition of the Leading Engagements to Advance Patient Care (LEAP) program.
Chronic care and GLP-1 therapeutics are reshaping the Indian Pharmaceutical Market as long-term therapies drive growth, demand, and investment.
Novartis India has approved a Rs 1,250 crore deal to acquire Pfizer's Minipress and Minipress trademarks in India. The deal also includes certain related intellectual property rights. The company’s board approved the transaction...
ProtExtent Biosolutions Pvt Ltd (PBPL), a biotechnology start-up based at the DBT-ILS Bioincubation Centre in Bhubaneswar, is making a strategically important move: the next major opportunity in vaccines may not be captured by producing
Centre’s HPV drive comes under watch as a PIL seeks Supreme Court intervention over consent, safety, and accountability.
.jpg "Why India Needs Global Regulatory Standards to Attract Pharma")
India’s pharma industry is looking beyond generics, but regulatory standards could determine how quickly it attracts global investment in innovation. Commerce and Industry Minister Piyush Goyal has called for greater alignment with developed...
Acquisitions and manufacturing steal the spotlight today as pharma companies pursue strategic deals, capacity expansion, and stronger market reach.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")